Times Square Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Times Square Capital Management, LLC
- $6.24 Billion
- Q3 2025
A detailed history of Times Square Capital Management, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Times Square Capital Management, LLC holds 267,505 shares of TARS stock, worth $19.3 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
267,505Holding current value
$19.3 Million% of portfolio
0.25%Shares
11 transactions
Others Institutions Holding TARS
# of Institutions
231Shares Held
45MCall Options Held
51.6KPut Options Held
15.8K-
Black Rock Inc. New York, NY3.27MShares$236 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.18MShares$229 Million2.52% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$217 Million5.63% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.67MShares$192 Million5.1% of portfolio
-
Jennison Associates LLC2.6MShares$188 Million0.09% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.92B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...